UNIverse - Public Research Portal
Project cover

THESEUS - an observational study on the use of entresto (sacubitril⁄valsartan) in clinical routine practice in Switzerland

Research Project
 | 
01.08.2016
 - 31.12.2018

Heart Failure is a common disease associated with a high mortality rate. Patients often experience severely impaired quality of life. After the introduction of the angiotensin converting enzyme (ACE) inhibitors, beta blockers and mineralocorticoid receptor antagonists, sacubitril/valsartan was the first drug demonstrating a significant reduction of mortality. So far, there is no data on the application of sacubitril/valsartan in Swiss primary care. The longitudinal, non-interventional THESEUS study will document implementation and dosing of sacubitril/valsartan over a period of 6 months in patients with heart failure in follow-up in a primary care setting in Switzerland. The THESEUS study is expected to deliver valuable real-world data on the use of sacubitril/valsartan in Swiss primary care, its tolerability and safety profile as well as its impact on the usage of healthcare resources.

Members (2)

MALE avatar

Thomas Dieterle

Principal Investigator
MALE avatar

Roger Hulin

Principal Investigator